- With the resignation of Merge Healthcare (MRGE -0.4%) Chairman Michael Ferro, Jr, RW Baird sees avenues for increasing shareholder value expanding. One potential option is a take-private transaction.
- Baird has an Overweight rating on the stock and a PT of $4.
- Before Q2's abysmal report, Baird had a PT of $7 on Merge, freshly hiked from $5.
at Zacks.com (Nov 17, 2014)